Additionally, while NQO1:CAT was not directly measured, inhibition of catalase and GSH did not lead to sensitization of KEAP1-mutated NSCLC during β-lapachone treatment, while inhibition of TXNRD and SOD1 sensitized cancers [29]. The gene discussed is KEAP1; the disease is cancer.